These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10769653

  • 1. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
    Khandaker MH, Kadhim SA, Ichim TE, Howson-Jan K, Chin J, Singhal SK.
    Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
    [Abstract] [Full Text] [Related]

  • 2. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
    Sindhwani P, Hampton JA, Baig MM, Keck R, Selman SH.
    J Urol; 2001 Oct; 166(4):1498-501. PubMed ID: 11547120
    [Abstract] [Full Text] [Related]

  • 3. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C, Yan RP, Yuan GH, Feng YG, Wang JS, Gao X, Huang YS, Zhou JB, Xie SS.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [Abstract] [Full Text] [Related]

  • 4. A murine model for bladder cancer.
    Murphy GP, Sandberg AA, Pontes JE, Ochi H, Yoshida M, Williams PD.
    Prog Clin Biol Res; 1984 Oct; 162A():177-200. PubMed ID: 6541340
    [Abstract] [Full Text] [Related]

  • 5. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen TS, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH.
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [Abstract] [Full Text] [Related]

  • 6. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
    Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD.
    Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
    [Abstract] [Full Text] [Related]

  • 7. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC, Sidky YA, Ertürk E, Wierenga W, Bryan GT.
    Cancer Res; 1990 Feb 15; 50(4):1071-4. PubMed ID: 2297754
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants.
    Chin J, Kadhim S, Garcia B, Kim YS, Karlik S.
    J Urol; 1991 Jun 15; 145(6):1297-301. PubMed ID: 2033720
    [Abstract] [Full Text] [Related]

  • 9. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS.
    Cancer Res; 1977 Aug 15; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
    Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, Moore RB.
    Br J Cancer; 1999 Oct 15; 81(4):638-46. PubMed ID: 10574249
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity.
    O'Donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK.
    J Urol; 2004 Mar 15; 171(3):1330-5. PubMed ID: 14767343
    [Abstract] [Full Text] [Related]

  • 12. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q, Mahendran R, Esuvaranathan K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526
    [Abstract] [Full Text] [Related]

  • 13. Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow-derived factor, reptimed.
    DeKoter RP, Parsons MF, Fong WG, Lin CH, Khalil W, Howson-Jan K, Singhal SK.
    Cell Immunol; 1997 Feb 01; 175(2):120-7. PubMed ID: 9023417
    [Abstract] [Full Text] [Related]

  • 14. Intravesical therapy with vinorelbine tartrate: antitumor activity in orthotopic murine cell carcinoma of the bladder.
    Bonfil RD, Russo DM, Schmilovich AJ, Garcia-Palazzo IB.
    J Urol; 1997 Sep 01; 158(3 Pt 1):912-5. PubMed ID: 9258118
    [Abstract] [Full Text] [Related]

  • 15. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K, Gleason D, Young JM, Saltzstein D, Gershman A, Lerner S, Witjes JA.
    J Urol; 2008 Jul 01; 180(1):116-20. PubMed ID: 18485407
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effects of polyribonucleotides for mouse transitional cell carcinoma enhanced by cyclophosphamide.
    Borden EC, Sidky YA, Groveman DS, Bryan GT.
    Cancer Res; 1985 Jan 01; 45(1):45-50. PubMed ID: 3965150
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A.
    Anticancer Res; 2009 Jun 01; 29(6):2067-76. PubMed ID: 19528466
    [Abstract] [Full Text] [Related]

  • 18. NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation.
    Smakman N, Schaap N, Snijckers CM, Borel Rinkes IH, Kranenburg O.
    Urology; 2005 Aug 01; 66(2):434-40. PubMed ID: 16098373
    [Abstract] [Full Text] [Related]

  • 19. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
    Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, Kaneda Y.
    Cancer Chemother Pharmacol; 2008 May 01; 61(6):973-8. PubMed ID: 17653716
    [Abstract] [Full Text] [Related]

  • 20. Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
    Saga Y, Hashimoto H, Yachiku S, Iwata T, Tokumitsu M.
    Int J Urol; 2004 Jun 01; 11(6):407-15. PubMed ID: 15157211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.